Kirkland Advises GBL on Acquisition of Affidea
Kirkland & Ellis is advising Groupe Bruxelles Lambert (“GBL”) on its first sizable investment in the healthcare sector with the acquisition of Affidea, the leading provider of medical diagnostic services in Europe. GBL will invest up to EUR 1.0 billion of equity into the transaction. Affidea is the leading European diagnostic imaging player, with 320 centres operating across 15 countries.
The Kirkland team was led by corporate partners Adrian Maguire and Francesca Harris and associates Jack Evans, Luke Forryan and Katy Henman; debt finance partners Evgeny Zborovsky and Sam Sherwood; tax partners Peter Abbott and Rob Sharpe and antitrust partners Thomas Wilson and Philipp Gnatzy.
